TY - JOUR
T1 - High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
AU - Zhu, Jie
AU - Yang, Wenjuan
AU - Zhou, Xiangda
AU - Zöphel, Dorina
AU - Soriano-Baguet, Leticia
AU - Dolgener, Denise
AU - Carlein, Christopher
AU - Hof, Chantal
AU - Zhao, Renping
AU - Ye, Shandong
AU - Schwarz, Eva C.
AU - Brenner, Dirk
AU - Prates Roma, Leticia
AU - Qu, Bin
N1 - Funding Information:
This project was funded by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 1027 project A2 to BQ, TRR219 (M04) to LP), INM Fellow, and HOMFOR2019 (to BQ) and Forschungsgroßgeräte (GZ: INST 256/423-1 FUGG and GZ: INST 256/419-1 FUGG) for flow cytometer and light-sheet microscope, respectively. LS-B and DB are funded by the FNR, respectively by the PRIDE (PRIDE/11012546/NEXTIMMUNE) and the ATTRACT program (A14/BM/7632103).
Funding Information:
We thank the Institute for Clinical Hemostaseology and Transfusion Medicine for providing donor blood; Annette Lis for mouse CD8+ T cell preparation and EG7-pCasper cells, Carmen H?ssig, Cora Hoxha and Gertrud Sch?fer for excellent technical help; Sandra Janku for her careful and critical reading; We are grateful to Markus Hoth for constant support, inspiring discussions and advice regarding writing of the manuscript. All the experiments except seahorse assay were conducted in Saarland University.
Publisher Copyright:
© Copyright © 2021 Zhu, Yang, Zhou, Zöphel, Soriano-Baguet, Dolgener, Carlein, Hof, Zhao, Ye, Schwarz, Brenner, Prates Roma and Qu.
PY - 2021/6/25
Y1 - 2021/6/25
N2 - Cytotoxic T lymphocytes (CTLs) are key players to eliminate tumorigenic or pathogen-infected cells using lytic granules (LG) and Fas ligand (FasL) pathways. Depletion of glucose leads to severely impaired cytotoxic function of CTLs. However, the impact of excessive glucose on CTL functions still remains largely unknown. Here we used primary human CD8+ T cells, which were stimulated by CD3/CD28 beads and cultured in medium either containing high glucose (HG, 25 mM) or normal glucose (NG, 5.6 mM). We found that in HG-CTLs, glucose uptake and glycolysis were enhanced, whereas proliferation remained unaltered. Furthermore, CTLs cultured in HG exhibited an enhanced CTL killing efficiency compared to their counterparts in NG. Unexpectedly, expression of cytotoxic proteins (perforin, granzyme A, granzyme B and FasL), LG release, cytokine/cytotoxic protein release and CTL migration remained unchanged in HG-cultured CTLs. Interestingly, additional extracellular Ca2+ diminished HG-enhanced CTL killing function. Our findings suggest that in an environment with excessive glucose, CTLs could eliminate target cells more efficiently, at least for a certain period of time, in a Ca2+-dependent manner.
AB - Cytotoxic T lymphocytes (CTLs) are key players to eliminate tumorigenic or pathogen-infected cells using lytic granules (LG) and Fas ligand (FasL) pathways. Depletion of glucose leads to severely impaired cytotoxic function of CTLs. However, the impact of excessive glucose on CTL functions still remains largely unknown. Here we used primary human CD8+ T cells, which were stimulated by CD3/CD28 beads and cultured in medium either containing high glucose (HG, 25 mM) or normal glucose (NG, 5.6 mM). We found that in HG-CTLs, glucose uptake and glycolysis were enhanced, whereas proliferation remained unaltered. Furthermore, CTLs cultured in HG exhibited an enhanced CTL killing efficiency compared to their counterparts in NG. Unexpectedly, expression of cytotoxic proteins (perforin, granzyme A, granzyme B and FasL), LG release, cytokine/cytotoxic protein release and CTL migration remained unchanged in HG-cultured CTLs. Interestingly, additional extracellular Ca2+ diminished HG-enhanced CTL killing function. Our findings suggest that in an environment with excessive glucose, CTLs could eliminate target cells more efficiently, at least for a certain period of time, in a Ca2+-dependent manner.
KW - Ca
KW - cytotoxic T lymphocytes
KW - cytotoxicity
KW - glucose uptake
KW - glycolysis
KW - high glucose
KW - migration
KW - proliferation
UR - http://www.scopus.com/inward/record.url?scp=85109647322&partnerID=8YFLogxK
UR - https://www.ncbi.nlm.nih.gov/pubmed/34248978
U2 - 10.3389/fimmu.2021.689337
DO - 10.3389/fimmu.2021.689337
M3 - Article
C2 - 34248978
AN - SCOPUS:85109647322
SN - 1664-3224
VL - 12
SP - 689337
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 689337
ER -